Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
RedactPHI
HIPAA-Compliant PHI Redaction
DetectICD10CM
ICD-10-CM Code Detection
Log in Register free account
1 code page views remaining. Guest accounts are limited to 1 page view. Register free account to get 5 more views.
Log in Register free account

Official Description

Subsequent placement of a drug-eluting ocular insert under one or more eyelids, including re-training, and removal of existing insert, unilateral or bilateral

© Copyright 2025 American Medical Association. All rights reserved.

Common Language Description

The procedure described by CPT® Code 0445T involves the subsequent placement of a drug-eluting ocular insert under one or more eyelids, which may be performed unilaterally or bilaterally. This insert is a specialized medical device designed to deliver medication directly to the ocular surface. The insert is thin, sterile, and multi-layered, consisting of an inner polymeric support that provides structural integrity, while the outer layer is infused with a specific drug or medication intended for therapeutic use. The device is strategically placed beneath the eyelid, resting on the conjunctiva, where it can effectively release the medication through controlled diffusion, facilitated by the permeation of lacrimal fluid through the outer membrane. During the procedure, the healthcare provider measures the intercanthal distance to select the appropriate size of the ocular insert. A topical ophthalmic anesthetic may be applied to minimize discomfort during the insertion process. The upper eyelid is then manually retracted to allow for the placement of the insert in the upper fornix, followed by the retraction of the lower eyelid, either manually or with the aid of a scleral depressor, to position the lower half of the insert in the lower fornix. It is important that a portion of the insert remains visible in the medial canthus for ease of management. After the placement, the patient receives instructions on how to care for the insert and manage any slight displacements that may occur. In cases where an existing insert needs to be removed, the procedure involves retracting the lower lid to expose the bottom half of the insert, allowing the healthcare provider to grip the exposed ring and gently pull it from the eye. This code specifically captures the nuances of re-training the patient on the care and management of the insert, as well as the removal and replacement of the device to ensure continued medication dosing.

© Copyright 2025 Coding Ahead. All rights reserved.

1. Indications

The procedure associated with CPT® Code 0445T is indicated for patients requiring ongoing medication delivery to the ocular surface through a drug-eluting ocular insert. The specific indications for this procedure include:

  • Chronic Ocular Conditions Patients suffering from chronic ocular conditions that necessitate sustained medication release, such as glaucoma or dry eye syndrome.
  • Medication Management Situations where continuous medication dosing is required to manage symptoms effectively and improve patient outcomes.
  • Replacement of Existing Inserts Cases where an existing ocular insert needs to be removed and replaced to ensure the efficacy of the treatment regimen.

2. Procedure

The procedure for the subsequent placement of a drug-eluting ocular insert involves several detailed steps to ensure proper insertion and patient comfort. The steps are as follows:

  • Step 1: Measurement of Intercanthal Distance The healthcare provider begins by measuring the intercanthal distance to determine the appropriate size of the ocular insert required for the patient. This measurement is crucial for ensuring that the insert fits correctly and functions as intended.
  • Step 2: Anesthetic Application A topical ophthalmic anesthetic is instilled in the eye to minimize discomfort during the procedure. This step is essential for patient comfort and cooperation during the insertion process.
  • Step 3: Upper Eyelid Retraction The upper eyelid is manually retracted to provide access to the upper fornix, where the insert will be placed. This retraction allows for a clear view and easier manipulation of the insert.
  • Step 4: Insertion into Upper Fornix The drug-eluting ocular insert is carefully placed in the upper fornix. The provider ensures that the insert is positioned correctly to allow for optimal drug release.
  • Step 5: Lower Eyelid Retraction The lower eyelid is then retracted, either manually or with the assistance of a scleral depressor, to facilitate the placement of the lower half of the insert in the lower fornix.
  • Step 6: Final Positioning The provider ensures that a portion of the insert is visible in the medial canthus, which is important for patient management and monitoring of the device.
  • Step 7: Patient Instruction After the successful placement of the insert, the patient is instructed on the proper care and management of the ocular insert, including how to handle any slight displacements that may occur during normal activities.

3. Post-Procedure

Post-procedure care following the placement of a drug-eluting ocular insert includes monitoring for any immediate discomfort or complications. Patients are advised to follow the care instructions provided by the healthcare provider, which may include guidelines on how to clean the area around the insert and what to do if the insert becomes displaced. Regular follow-up appointments may be scheduled to assess the effectiveness of the medication delivery and to ensure that the insert remains properly positioned. Patients should also be educated on signs of potential complications, such as increased irritation or changes in vision, and instructed to seek medical attention if these occur.

Short Descr SBSQT PLMT DRUG ELUT OC INS
Medium Descr SBSQ PLMT DRUG ELUTING OCULAR INSERT UNI/BI
Long Descr Subsequent placement of a drug-eluting ocular insert under one or more eyelids, including re-training, and removal of existing insert, unilateral or bilateral
Status Code Carriers Price the Code
Global Days YYY - Carrier Determines Whether Global Concept Applies
PC/TC Indicator (26, TC) 0 - Physician Service Code
Multiple Procedures (51) 0 - No payment adjustment rules for multiple procedures apply.
Bilateral Surgery (50) 0 - 150% payment adjustment for bilateral procedures does NOT apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 0 - Payment restriction for assistants at surgery applies to this procedure...
Co-Surgeons (62) 0 - Co-surgeons not permitted for this procedure.
Team Surgery (66) 0 - Team surgeons not permitted for this procedure.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Items and Services Packaged into APC Rates
ASC Payment Indicator Packaged service/item; no separate payment made.
Berenson-Eggers TOS (BETOS) P5E - Ambulatory procedures - other
MUE 1
Date
Action
Notes
2017-01-01 Added First appearance in codebook.
2016-07-01 Added Code Added.
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"